Related Experiment Video
Updated: May 30, 2026
09:29
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Immune mechanisms in hypertension.
Avshalom Leibowitz1, Ernesto L Schiffrin
1Lady Davis Institute for Medical Research, McGill University, Montreal, PQ, Canada.
Current Hypertension Reports
|August 16, 2011
Summary
Immune responses, including inflammation and cytokine production, contribute to hypertension development and organ damage. Understanding these immune mechanisms is key to managing high blood pressure.
Area of Science:
- Immunology
- Cardiovascular Science
- Nephrology
Background:
- Inflammation is a key factor in hypertension pathogenesis.
- Both innate and adaptive immune responses are implicated.
- Mechanisms linking immune response to hypertension are not fully understood.
Purpose of the Study:
- To review recent data on immune cell subsets in hypertension.
- To elucidate immune response mechanisms promoting hypertension.
- To discuss immune contributions to target-organ damage.
Main Methods:
- Review of existing literature on immune response in hypertension.
- Analysis of data concerning cytokine production.
- Examination of central nervous system (CNS) stimulation and kidney damage roles.
Main Results:
- Proinflammatory cytokine microenvironments can cause low-grade inflammation, vascular injury, and end-organ damage.
- CNS stimulation, e.g., by angiotensin II, can modulate peripheral immune responses, worsening hypertension.
- Immune responses can lead to kidney injury and impaired sodium excretion, elevating blood pressure.
Conclusions:
- Immune cell subsets play a significant role in hypertension and associated organ damage.
- Cytokine production, CNS stimulation, and kidney damage are critical pathways.
- Further research into immune mechanisms is vital for hypertension management.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...